ELASTIMED LTD

Their core work

ElastiMed is an Israeli medical device SME developing smart compression garments using Electro-Active Polymer (EAP) technology. Their core product, ComFyt, replaces traditional passive compression stockings — used to treat chronic venous insufficiency, lymphedema, and post-surgical recovery — with an active, electronically controlled alternative that patients can actually wear comfortably. The technology applies EAP materials to generate controlled, adjustable pressure on the limb without the discomfort and donning difficulty that causes widespread patient non-compliance with conventional compression therapy. Their work sits at the intersection of smart materials, medical wearables, and rehabilitation technology.

What they specialise in

How they've shifted over time

ElastiMed's H2020 trajectory is a textbook SME Instrument progression: a 2017 Phase 1 feasibility study confirmed the market and technical concept, followed immediately by a 2018 Phase 2 full development grant of €1.3M to build and validate the product. This is not a shift in focus — it is a deepening of a single focused bet on EAP-based compression therapy. No keyword data is available to detect finer thematic shifts, so this observation is based solely on project structure and funding scheme.

ElastiMed is a single-product company in active development mode; any future collaboration would likely be in clinical validation, regulatory affairs, or manufacturing scale-up rather than fundamental research.

How they like to work

ElastiMed has used the SME Instrument exclusively — a funding scheme designed for single-company applications, meaning they have operated without consortium partners in both H2020 projects. They are project coordinators by record, but in practice these were solo efforts. This suggests a company that is highly self-contained in its core technology but may need external partners for clinical trials, distribution, or market entry as it moves toward commercialization.

ElastiMed has zero recorded consortium partners across both H2020 projects, reflecting the solo nature of the SME Instrument scheme. Their network within the EU project ecosystem is effectively non-existent on paper, though they are based in Misgav Industrial Park — a high-tech cluster in northern Israel with links to medical device and materials companies.

What sets them apart

ElastiMed is one of very few organizations applying Electro-Active Polymer actuation specifically to the compression garment market — a large but technologically stagnant medical device segment. Most compression therapy innovation has been incremental (pressure gradients, better fabrics); ElastiMed's EAP approach is a platform-level departure that could extend to other body areas and therapeutic indications. For a potential partner, they offer proprietary materials know-how in a health application with clear commercial pull, not just a research concept.

Highlights from their portfolio

• ComFyt (SME-2)
  The largest grant (€1,336,142) and full development phase of ElastiMed's core technology, making it the definitive project for understanding their commercial-stage capabilities.
• ComFyt (SME-1)
  The Phase 1 feasibility award demonstrates that an independent EU evaluator validated both the market case and technical concept before the larger investment was made.